Clinical Trials Browser

Prostatic Neoplasms × Interleukin-2 × Clear all

NCT07410494 2026-02-18

SELECT-CAR-NK

Phase 1/2 Recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Liver Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute

NCT00004050 2014-07-29

Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT00005072 2014-07-29

Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer

Phase 1/2 Terminated

Prostatic Neoplasms

NCT00283829 2007-11-29

Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms

NCT00040586 2007-01-22

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Phase 2 Completed

Prostatic Neoplasms